41 related articles for article (PubMed ID: 29748887)
1. The predictive value of histological tumor regression grading (TRG) for therapeutic evaluation in locally advanced esophageal carcinoma treated with neoadjuvant chemotherapy.
Guo K; Cai L; Zhang Y; Zhu JF; Rong TH; Lin P; Hao CL; Wang WP; Li Z; Zhang LJ
Chin J Cancer; 2012 Aug; 31(8):399-408. PubMed ID: 22572013
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of nodal status and lymphovascular invasion in patients undergoing neoadjuvant chemotherapy for esophageal squamous cell carcinoma.
Miyata H; Sugimura K; Kanemura T; Takeoka T; Sugase T; Yasui M; Nishimura J; Wada H; Akita H; Yamamoto M; Hara H; Shinno N; Omori T; Yano M
Dis Esophagus; 2024 May; ():. PubMed ID: 38693752
[TBL] [Abstract][Full Text] [Related]
3. ASO Author Reflections: Impact of Metastatic Lymph Nodes on Survival of Patients with pN1-Category Esophageal Squamous Cell Carcinoma.
Li K; Leng X; Peng L
Ann Surg Oncol; 2024 Jun; 31(6):3850-3851. PubMed ID: 38466485
[No Abstract] [Full Text] [Related]
4. Comment on "Neoadjuvant Chemotherapy or Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Real-World Data Comparison from a Japanese Nationwide Study".
Gronnier C
Ann Surg Oncol; 2024 May; 31(5):2815-2817. PubMed ID: 38355781
[No Abstract] [Full Text] [Related]
5. Higher overall survival rates of oral squamous cell carcinoma treated with metronomic neoadjuvant chemotherapy.
Kina S; Miyamoto S; Kawabata-Iwakawa R; Kina-Tanada M; Ogawa M; Yokoo S
Am J Cancer Res; 2024; 14(3):1033-1051. PubMed ID: 38590400
[TBL] [Abstract][Full Text] [Related]
6. Transcriptomic biomarkers for predicting response to neoadjuvant treatment in oesophageal cancer.
Lavery A; Turkington RC
Gastroenterol Rep (Oxf); 2020 Dec; 8(6):411-424. PubMed ID: 33442473
[TBL] [Abstract][Full Text] [Related]
7. ASO Author Reflections: Tumor Response After the First Course of Neoadjuvant Chemotherapy Reflects Prognosis After Surgery in Patients with Esophageal Squamous Cell Carcinoma.
Hagi T; Shiraishi O; Yasuda T
Ann Surg Oncol; 2024 May; ():. PubMed ID: 38702391
[No Abstract] [Full Text] [Related]
8. Indications for neoadjuvant chemotherapy in older patients undergoing esophagectomy for esophageal cancer.
Yamashita K; Momose K; Tanaka K; Makino T; Saito T; Yamamoto K; Takahashi T; Kurokawa Y; Nakajima K; Eguchi H; Doki Y
Surg Today; 2024 May; 54(5):442-451. PubMed ID: 37903923
[TBL] [Abstract][Full Text] [Related]
9. Distribution of residual tumors in esophageal squamous cell carcinoma after neoadjuvant PD-1 blockade combined with chemotherapy.
Jiang D; Song Q; Tang H; Shi P; Zhang X; Liu Y; Wang H; Deng M; Huang J; Su J; Xu C; Tan L; Hou Y
Front Oncol; 2023; 13():1067897. PubMed ID: 36925921
[TBL] [Abstract][Full Text] [Related]
10. Significance of dissection in each regional lymph-node station of esophageal cancer based on efficacy index and recurrence patterns after curative esophagectomy.
Kanemura T; Miyata H; Takeoka T; Sugase T; Sugimura K; Yamashita K; Tanaka K; Makino T; Ota M; Yagi K; Toh Y; Seto Y; Doki Y
Esophagus; 2023 Jul; 20(3):402-409. PubMed ID: 36574141
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of taxanes following nivolumab in patients with advanced esophageal squamous cell carcinoma: a retrospective chart review of patients in ATTRACTION-3.
Chin K; Yamamoto S; Takahashi M; Kadowaki S; Kubota Y; Amanuma Y; Okada M; Kanda M; Kimura Y; Nogi Y; Arimitsu Y; Kitagawa Y
Esophagus; 2023 Apr; 20(2):302-308. PubMed ID: 36564602
[TBL] [Abstract][Full Text] [Related]
12. Tri-modality therapy in advanced esophageal carcinoma: long-term results and insights from a developing world, institutional cohort.
Chufal KS; Ahmad I; Bajpai R; Miller AA; Chowdhary RL; Makker J; Batra U; Nathany S; Sharief MI; Umesh P; Sharma M; Amrith P; Pahuja AK; Sethi J; Antony V; Gairola M
Br J Radiol; 2023 Mar; 96(1143):20220413. PubMed ID: 36541255
[TBL] [Abstract][Full Text] [Related]
13. Applying post-neoadjuvant pathologic stage as prognostic tool in esophageal squamous cell carcinoma.
Han W; Deng W; Wang Q; Ni W; Li C; Zhou Z; Liang J; Chen D; Feng Q; Bi N; Zhang T; Wang X; Deng L; Wang W; Liu W; Wang J; Xue Q; Mao Y; Liu X; Fang D; Li J; Wang D; Zhao J; Xiao Z
Front Oncol; 2022; 12():998238. PubMed ID: 36439431
[TBL] [Abstract][Full Text] [Related]
14. Clinical impact of remnant lymphatic invasion on the recurrence of esophageal squamous cell carcinoma after esophagectomy with neoadjuvant chemotherapy.
Okuda S; Ohuchida K; Shindo K; Moriyama T; Kawata J; Tamura K; Sada M; Nagayoshi K; Mizuuchi Y; Ikenaga N; Nakata K; Oda Y; Nakamura M
Oncol Lett; 2022 Oct; 24(4):337. PubMed ID: 36039060
[TBL] [Abstract][Full Text] [Related]
15. Is there value of tumor stromal infiltrating lymphocytes for response assessment to chemoradiation in esophageal squamous cell carcinoma?
Wang X; Jing W; Lin SH
Ann Transl Med; 2019 Dec; 7(Suppl 8):S283. PubMed ID: 32016002
[No Abstract] [Full Text] [Related]
16. The Impact of Pathological Tumor Regression and Nodal Status on Survival and Systemic Disease in Patients Undergoing Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma.
Miyata H; Tanaka K; Makino T; Yamasaki M; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Morii E; Mori M; Doki Y
Ann Surg Oncol; 2018 Aug; 25(8):2409-2417. PubMed ID: 29748887
[TBL] [Abstract][Full Text] [Related]
17. Oncologic Outcomes According to Remnant Lymph Node Metastases in Pathologic T0 (ypT0) Esophageal Squamous Cell Carcinoma Following Prospective Neoadjuvant Therapy and Surgery.
Cho HJ; Kim YH; Kim HR; Kim DK; Park SI; Kim JH; Kim SB
Ann Surg Oncol; 2015; 22(6):1851-7. PubMed ID: 25344308
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemoradiotherapy followed by esophagectomy for initially resectable squamous cell carcinoma of the esophagus with multiple lymph node metastasis.
Nabeya Y; Ochiai T; Matsubara H; Okazumi S; Shiratori T; Shuto K; Aoki T; Miyazaki S; Gunji Y; Uno T; Ito H; Shimada H
Dis Esophagus; 2005; 18(6):388-97. PubMed ID: 16336610
[TBL] [Abstract][Full Text] [Related]
19. Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification.
Schneider PM; Baldus SE; Metzger R; Kocher M; Bongartz R; Bollschweiler E; Schaefer H; Thiele J; Dienes HP; Mueller RP; Hoelscher AH
Ann Surg; 2005 Nov; 242(5):684-92. PubMed ID: 16244542
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
